SecBot SecBot
SECBOTREPLAY Home › Report › RYTM

RYTM · David Meeker, a director and officer of Rhythm Pharmaceuticals, filed a…

RHYTHM PHARMACEUTICALS, INC. · 144 filed Sep 14, 2026 at 16:49 ET

At the news

BEARISHIMPACT 5/10

144 filed Sep 14, 2026 at 16:49 ET

David Meeker, a director and officer of Rhythm Pharmaceuticals, filed a Form 144 notice of intent to sell 50,000 shares of common stock with an approximate market value of $5.24 million. The shares are to be sold through Morgan Stanley and were acquired via stock option exercise. This is a notable insider sale from a top executive at a $7.2B market cap biotech, though the filing is an advance notice of intent, not a completed transaction.

  • David Meeker (Director and Officer) filed Form 144 to sell 50,000 shares.
  • Estimated sale value: ~$5,235,500 based on filing date market price.
  • Shares to be sold through Morgan Stanley Smith Barney LLC.
  • Shares acquired via exercise of stock options on 09/14/2026.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access